Rapid Dose Therapeutics Corp (DOSE) Stock Price & News

All values in CAD	2025-ж. авг.	2025-ж. ноя.	2026-ж. фев.	2026-ж. май
Revenue	672,92 миң	657,14 миң	660,52 миң	584,52 миң
Cost of goods sold	296,47 миң	347,34 миң	375,36 миң	272,66 миң
Cost of revenue	296,47 миң	347,34 миң	375,36 миң	272,66 миң
Research and development expenses	19,39 миң	15,20 миң	13,14 миң	-170,00
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	691,93 миң	792,49 миң	543,31 миң	419,38 миң
Operating expense	919,24 миң	998,15 миң	721,18 миң	539,58 миң
Total operating expenses	1,22 млн	1,35 млн	1,10 млн	812,25 миң
Operating income	-542,79 миң	-688,35 миң	-436,03 миң	-227,73 миң
Other non operating income	-	-	-	-
EBT including unusual items	-825,47 миң	-1,14 млн	-700,00 миң	-503,70 миң
EBT excluding unusual items	-825,47 миң	-1,14 млн	-700,00 миң	-503,70 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-825,47 миң	-1,14 млн	-700,00 миң	-503,70 миң
Net profit margin	-122,67%	-173,56%	-105,98%	-86,17%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-282,69 миң	-452,16 миң	-263,97 миң	-275,97 миң
Net interest expenses	-282,69 миң	-452,16 миң	-263,97 миң	-275,97 миң
Depreciation and amortization charges	135,20 миң	126,60 миң	117,86 миң	120,37 миң
EBITDA	-501,96 миң	-656,12 миң	-393,20 миң	-192,89 миң
Gain or loss from assets sale	-	-	-	-

Finance